Oak Street Health (NYSE:OSH) – Equities research analysts at William Blair upped their Q3 2020 earnings estimates for shares of Oak Street Health in a research report issued to clients and investors on Thursday, September 17th. William Blair analyst R. Daniels now anticipates that the company will post earnings of ($0.15) per share for the quarter, up from their prior forecast of ($0.16). William Blair has a “Outperform” rating on the stock. William Blair also issued estimates for Oak Street Health’s Q4 2020 earnings at ($0.20) EPS and FY2020 earnings at ($0.57) EPS.
Oak Street Health (NYSE:OSH) last posted its quarterly earnings results on Wednesday, September 16th. The company reported ($72.53) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.12) by ($72.41).
Shares of OSH stock opened at $42.27 on Monday. Oak Street Health has a twelve month low of $37.11 and a twelve month high of $53.58.
In other Oak Street Health news, Director Kim Keck purchased 5,000 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was purchased at an average price of $21.00 per share, with a total value of $105,000.00. Following the acquisition, the director now owns 5,000 shares in the company, valued at $105,000. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Oak Street Health Company Profile
Oak Street Health, Inc, through its subsidiaries, engages in designing and building the Oak Street platform to address the unmet needs of the chronically ill Medicare population in the United States. It operates primary care centers serving Medicare beneficiaries. The company contracts with health plans to generate medical costs savings and realize a return on its investment in primary care.
Read More: Dividend
Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.